Combined with our immunohistochemistry results showed that TROP2 was highly expressed in Ki67 positive proliferating cells, these data indicated that the expression of TROP2 increased the cell viability of cervical cancer cells. The gene discussed is TACSTD2; the disease is cervical cancer.